Dear Tangentland,
Good post, we have seen programs get cancelled before with PoH and takeovers, however this time I think is a bit different.
You may recall a few weeks back ie Dec 2013, PoH turned up as a Top 5 company to watch in 2013 out of over 1300 companies evaluated, and all here were stunned. Ie how did this happen, what do they know that we don't, how did a little Australian Bio come to the attention of Lux? Was there talk around the US bio sector we didn't know about or was it industry insiders talking.
Now fast forward 3 weeks and surprise surprise surprise, Pfizer is looking at taking over a related company that POH has a license with.
Isn't the chairman of Lux a former Pfizer CEO?
Looks like someone was playing golf with someone and gee wiz Lux luck out with some inside Pfizer goss that then focuses the analysts onto a little Australian biotech.
Outcome, Lux get made to look like heroes with a Top 5 call.
This is really starting to get interesting.
BSW
- Forums
- ASX - By Stock
- pfizer considers t/o of agila specialties
Dear Tangentland,Good post, we have seen programs get cancelled...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $205 | 72.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
62 | 90468113 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 61728026 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
62 | 90468113 | 0.002 |
22 | 73500009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 61728026 | 18 |
0.004 | 22093142 | 20 |
0.005 | 20469333 | 10 |
0.006 | 20865067 | 11 |
0.007 | 10865221 | 9 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |